Unknown

Dataset Information

0

ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.


ABSTRACT: Human embryonic stem cells (hESCs) offer a potentially unlimited supply of cells for emerging cell-based therapies. Unfortunately, the process of deriving distinct cell types can be time consuming and expensive. In the developed world, age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with more than 7.2 million people afflicted in the U.S. alone. Both hESC-derived retinal pigmented epithelium (hESC-RPE) and induced pluripotent stem cell-derived RPE (iPSC-RPE) are being developed for AMD therapies by multiple groups, but their potential for expansion in culture is limited. To attempt to overcome this passage limitation, we examined the involvement of Rho-associated, coiled-coil protein kinase (ROCK) in hESC-RPE and iPSC-RPE culture. We report that inhibiting ROCK1/2 with Y-27632 allows extended passage of hESC-RPE and iPSC-RPE. Microarray analysis suggests that ROCK inhibition could be suppressing an epithelial-to-mesenchymal transition through various pathways. These include inhibition of key ligands of the transforming growth factor-? pathway (TGFB1 and GDF6) and Wnt signaling. Two important processes are affected, allowing for an increase in hESC-RPE expansion. First, ROCK inhibition promotes proliferation by inducing multiple components that are involved in cell cycle progression. Second, ROCK inhibition affects many pathways that could be converging to suppress RPE-to-mesenchymal transition. This allows hESC-RPE to remain functional for an extended but finite period in culture.

SUBMITTER: Croze RH 

PROVIDER: S-EPMC4149306 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium.

Croze Roxanne H RH   Buchholz David E DE   Radeke Monte J MJ   Thi William J WJ   Hu Qirui Q   Coffey Peter J PJ   Clegg Dennis O DO  

Stem cells translational medicine 20140728 9


Human embryonic stem cells (hESCs) offer a potentially unlimited supply of cells for emerging cell-based therapies. Unfortunately, the process of deriving distinct cell types can be time consuming and expensive. In the developed world, age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with more than 7.2 million people afflicted in the U.S. alone. Both hESC-derived retinal pigmented epithelium (hESC-RPE) and induced pluripotent stem cell-derived RPE (iPSC-RP  ...[more]

Similar Datasets

2014-06-30 | E-GEOD-56618 | biostudies-arrayexpress
2014-06-30 | GSE56618 | GEO
| S-EPMC5132148 | biostudies-literature
| S-EPMC9311890 | biostudies-literature
| S-EPMC5911695 | biostudies-literature
| S-EPMC5767671 | biostudies-literature
2010-11-10 | GSE25143 | GEO
2010-11-10 | E-GEOD-25143 | biostudies-arrayexpress
| S-EPMC8602392 | biostudies-literature
| S-EPMC9461284 | biostudies-literature